06/17/2026
Critical researchers are looking for potential candidates to help fulfill their clinical trial. This study is designed to evaluate immune response to a MUC1 vaccine which ultimately hopes to prevent disease reoccurrence. To find out more or to become a candidate, full details can be found in the link below.
Study Details | NCT06218303 | Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ | ClinicalTrials.gov
https://clinicaltrials.gov/study/NCT06218303